North M E, Webster A D, Farrant J
Immune Deficiency Diseases Research Group, Clinical Research Centre, Harrow, England.
Clin Exp Immunol. 1990 Sep;81(3):412-6. doi: 10.1111/j.1365-2249.1990.tb05348.x.
We have assessed the ability of interleukin-2 (IL-2) and interleukin-6 (IL-6) to augment the proliferative response of T lymphocytes from 'common-variable' hypogammaglobulinaemia (CVH) patients and from normal controls, to the mitogens phytohaemagglutinin (PHA) and OKT3. We show that with cells from the control group and from those patients whose T cells respond to PHA within the control range, both IL-2 and IL-6 will significantly augment the response to OKT3. However, in those patients with a T cell defect in which the PHA response is below the control range, neither IL-2 nor IL-6 could restore the PHA or OKT3 response to normal. Responses to IL-2 or IL-6 alone were always in or above the control range.
我们评估了白细胞介素-2(IL-2)和白细胞介素-6(IL-6)增强来自“常见变异型”低丙种球蛋白血症(CVH)患者及正常对照者的T淋巴细胞对丝裂原植物血凝素(PHA)和OKT3的增殖反应的能力。我们发现,对于对照组以及T细胞对PHA的反应在对照范围内的患者的细胞,IL-2和IL-6均能显著增强对OKT3的反应。然而,在那些T细胞存在缺陷且PHA反应低于对照范围的患者中,IL-2和IL-6均无法将PHA或OKT3反应恢复至正常。单独对IL-2或IL-6的反应始终在对照范围内或高于对照范围。